Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Clin Exp Pharmacol Physiol. 2021 Apr 21;48(7):943–953. doi: 10.1111/1440-1681.13500

Table 1.

Therapeutic modulators of autophagy.

Modulators Name/Source Function Ref
A769662 Direct AMPK activator Induces AMPK-mediated autophagy and clearance of α-synuclein in neurons 100
AUTEN-67 Autophagy enhancer-67 Induces autophagy by modulating MTORC1 in AD 101
CysC Cystatin C Induces autophagy by manipulating AMPK-MTORC1 axis and inhibits aggregation of Aβ 102
Digoxin Natural compound Induces autophagy in a TFEB-dependent fashion 103
GSK621 Specific AMPK agonist Induces AMPK-mediated autophagy and clearance of α-synuclein in neurons 100
Latrepirdine Pharmaceutical compound Induces autophagy in MTORC1-dependent manner, ameliorates yeast model of AD, and upregulates ATG5 104,105
Metformin N,N-dimethylbiguanide Exerts neuroprotection and reduces cognitive decline via AMPK-mediated autophagy 106
MSL Synthetic autophagy upregulator Activates calcineurin, leading to dephosphorylation of TFEB that translocates to nucleus and upregulate ATG genes, and blocks neurodegeneration inflammation 107
Resveratrol Found in peanuts, red grapes, and blueberries Enhances degradation of α-synuclein in in vivo models of PD via inducing AMPK-SIRT1-mediated autophagy 108
RSVA314 and RSVA405 Synthetic molecules Activate CAMKK2-AMPK axis, leading to autophagy induction and Aβ clearance 109

Abbreviations: TFEB (transcription factor EB), SIRT1 (sirtuin 1)